Drug General Information (ID: DDIF30E9RN)
  Drug Name Metformin Drug Info Ethanol Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antidiabetic Agents Analgesics
  Structure

 Mechanism of Metformin-Ethanol Interaction (Severity Level: Major)
     Increased risk of hypoglycemia Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Metformin Ethanol
      Mechanism Antidiabetic agent Hypoglycemic effects
      Key Mechanism Factor 1
Factor Name Hypoglycemia
Factor Description Hypoglycemia is a condition in which your blood sugar (glucose) level is below the standard range. It causes irregular or rapid heartbeat, pale skin, numbness of the lips, tongue or cheeks, and sweating.
      Mechanism Description
  • Increased risk of hypoglycemia by the combination of Metformin and Ethanol 

Recommended Action
      Management Excessive alcohol intake should be avoided during treatment with metformin. Diabetes patients in general should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis. Alcohol should not be consumed on an empty stomach or following exercise, as it may increase the risk of hypoglycemia. Patients should contact their physician immediately if they experience potential signs and symptoms of lactic acidosis such as malaise, myalgia, respiratory distress, increasing somnolence, and nonspecific abdominal distress (especially after stabilization of metformin therapy, when gastrointestinal symptoms are uncommon). With more marked acidosis, there may also be associated hypothermia, hypotension, and resistant bradyarrhythmias. Metformin should be withdrawn promptly if lactic acidosis is suspected. Serum electrolytes, ketones, blood glucose, blood pH, lactate levels, and blood metformin levels may be useful in establishing a diagnosis. Lactic acidosis should be suspected in any diabetic patient with metabolic acidosis lacking evidence of ketoacidosis (ketonuria and ketonemia).

References
1 Product Information. Glucophage (metformin). Bristol-Myers Squibb, Princeton, NJ.
2 Position Statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes related complications. American Diabetes Association. Diabetes Care 25(Suppl 1) (2002): S50-S60.[PMID: 11772917]